People In Brief
This article was originally published in The Tan Sheet
Hennessey jumps to Prestige from Pfizer
You may also be interested in...
EC drug goes nonprescription in Ireland
House Shows Nanotech Safety Interest With Bill To Sharpen Federal Plan
The House Committee on Science and Technology will consider legislation crafted to provide strategic direction to the federal research program for nanotechnology
The Illumina Shareholder Votes Are In, And Nobody Got What They Wanted
Carl Icahn was successful in ousting Illumina’s chair, however its CEO, Francis deSouza remains. Both analysts and investors believe this could further encourage Illumina to divest Grail.